Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…
Latest Podcasts
BS Medicine Episode #612: Can fezolinetant improve vasomotor symptoms in menopause?
In episode 612, Tina and James chat with Samantha Moe about the use of a recently approved non-hormonal medication being used for vasomotor symptoms in menopause. We go over the…
BS Medicine Episode #611: Meds for Essential Tremor: Steady solution or shaky science?
In episode 611, Tina and James talk with Samantha Moe about the use of betablockers and other medications for essential tremor. There is some evidence – much of it from…
In the Clinic Episode 52: Statins in the Elderly
In this episode of In the Clinic the team discusses Ticker Endo, a 81 year old who would like a general medication review. To earn an additional 0.25 credits, please…
September 19, 2024
Presenter(s):
Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
Please provide any additional comments (optional).